Emotional Benefits of Probiotics; Phase III Success for ADHD Tx | MedPage Today

Probiotics paired with prebiotics may hold a place in depression and anxiety treatment regimens, according to a review of seven studies. (The BMJ)

The investigational treatment vafidemstat-- an oral KDM1A inhibitor -- effectively reduced aggression in patients with borderline personality disorder, ADHD, and autism in the phase IIa Reimagine trial, Oryzon Genomics announced.

Sunovion said its SEP-4199 amisulpride formulation failed to meet its primary endpoint after six weeks in a phase II trial targeting major depressive episodes associated with bipolar I disorders..

https://www.medpagetoday.com/psychiatry/generalpsychiatry/87463


Comments

Popular posts from this blog

Integron activity accelerates the evolution of antibiotic resistance | eLife

The incredible bacterial 'homing missiles' that scientists want to harness

Aluminum and Tau in Neurofibrillary Tangles in Familial Alzheimer’s Disease - IOS Press